Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China

Study (n=1,115) reports an incidence of 3.77% for anti-TB drug-induced hepatotoxicity in this population; stating the therapeutic combination of isoniazid, rifampicin and ethambutol (HRE) might be the safest.

Source:

European Journal of Hospital Pharmacy